The Optima Study: Earlier Intervention of Cinacalcet Hcl (Sensipar (R)/Mimpara (R)) Enables Greater Achievement of Kdoqi (Tm) Secondary Hyperparathyroidism (Shpt) Targets in Dialysis Patients.
AuthID
P-004-MAQ
P-004-MAQ